Información del autor
Autor Caviedes, L. |
Documentos disponibles escritos por este autor (2)
Añadir el resultado a su cesta Hacer una sugerencia Refinar búsqueda
texto impreso
Trollip, A. P. ; Moore, D. ; Coronel, J. ; Caviedes, L. ; Klages, S. ; Victor, T. ; Romancenco, E. ; Crudu, V. ; Ajbani, K. ; Vineet, V. P. ; Rodrigues, C. ; Jackson, R. L. ; Eisenach, K. ; Garfein, R. S. ; Rodwell, T. C. ; Desmond, E. ; Groessl, E. J. ; Ganiats, T. G. ; Catanzaro, A. | International Union Against Tuberculosis and Lung Disease | 2020-06-10T18:11:35ZOBJECTIVE: To establish breakpoint concentrations for the fluoroquinolones (moxifloxacin [MFX] and ofloxacin [OFX]) and injectable second-line drugs (amikacin [AMK], kanamycin [KM] and capreomycin [CPM]) using the microscopic observation drug su[...]texto impreso
Coronel, J. ; Roper, M. H. ; Herrera, C. ; Bonilla, C. ; Jave, O. ; Gianella, C. ; Sabogal, I. ; Huancare, V. ; Leo, E. ; Tyas, A. ; Mendoza-Ticona, A. ; Caviedes, L. ; Moore, D. a. J. | Elsevier | 2020-06-10T18:11:31ZDrug susceptibility testing (DST) is often needed in patients clinically failing tuberculosis (TB) therapy. Most studies of phenotypic direct drug susceptibility tests, such as microscopic observation drug susceptibility (MODS) tests, have bee[...]